Valuation: Merck KGaA

Market Cap 62.3B 69.77B 57.56B 52.16B 97.58B 6,623B 99.2B 693B 274B 3,470B 262B 256B 10,940B P/E 2026 *
24.2x
P/E 2027 * 21.3x
Enterprise Value 70.06B 78.45B 64.72B 58.65B 110B 7,447B 112B 779B 308B 3,902B 294B 288B 12,301B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 3.01x
Free-Float
29.73%
Yield 2026 *
1.64%
Yield 2027 * 1.68%
1 day-2.08%
1 week-0.69%
Current month+3.77%
1 month+6.98%
3 months+2.98%
6 months+28.06%
Current year+16.88%
1 week 141.6
Extreme 141.6
147.55
1 month 132.95
Extreme 132.95
147.55
Current year 100.7
Extreme 100.7
148.8
1 year 100.7
Extreme 100.7
148.8
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 61 2026-04-30
Director of Finance/CFO 56 2023-06-30
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 2019-04-25
Director/Board Member 60 2014-05-08
Director/Board Member 50 2020-05-27
Date Insider Type Main position Quantity % Market Cap. Importance
3/25/26 Buy

Chief Executive Officer

3,386 0.0026%
3/25/26 Buy

Chief Financial Officer

4,563 0.0035%
3/27/25 Buy 1,401 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-2.08%-0.69%+24.55%-2.32% 69.77B
-2.54%+1.31%+54.27%+114.96% 1,135B
-1.42%+3.23%+38.56%+74.44% 635B
+0.16%+0.08%+25.29%+95.23% 505B
-0.31%+3.09%+44.14%+64.80% 378B
-1.34%-0.47%+66.04%+41.00% 358B
-0.68%+2.65%+22.98%+50.39% 295B
-1.20%+3.04%+2.33%+22.86% 266B
-1.79%+1.57%+50.56%+59.08% 237B
-0.73%-0.10%+29.02%+99.67% 193B
Average -1.19%+1.88%+35.77%+62.01% 407.34B
Weighted average by Cap. -1.36%+2.60%+40.74%+78.35%

Financials

2026 *2027 *
Net sales 21.49B 24.06B 19.85B 17.99B 33.66B 2,284B 34.21B 239B 94.58B 1,197B 90.31B 88.39B 3,773B 22.67B 25.39B 20.94B 18.98B 35.51B 2,410B 36.1B 252B 99.78B 1,263B 95.28B 93.25B 3,981B
Net income 2.56B 2.86B 2.36B 2.14B 4.01B 272B 4.07B 28.44B 11.26B 142B 10.75B 10.52B 449B 2.86B 3.2B 2.64B 2.39B 4.48B 304B 4.55B 31.77B 12.58B 159B 12.01B 11.76B 502B
Net Debt 7.75B 8.68B 7.16B 6.49B 12.14B 824B 12.34B 86.18B 34.12B 432B 32.58B 31.89B 1,361B 5.83B 6.52B 5.38B 4.88B 9.13B 619B 9.28B 64.77B 25.64B 325B 24.49B 23.97B 1,023B
Projected Income Statement - Annual - Merck KGaA
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
62,136
Date Price Change Volume
26-10-23 €143.30 -2.08% 218,447
26-10-22 €146.35 +2.88% 301,475
26-10-21 €142.25 -2.83% 521,827
26-10-20 €146.40 +1.42% 266,768
26-10-19 €144.35 +0.03% 240,355
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Merck KGaA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
143.30EUR
Average target price
154.21EUR
Spread / Average Target
+7.62%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Merck KGaA